−£6.87m
vs Dec 2023Active14462405Private limited companyLondon
CODIFY THERAPEUTICS LIMITED
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Codify Therapeutics Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
CODIFY THERAPEUTICS LIMITED is an active private limited company (company number 14462405) incorporated on 4 November 2022, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 December 2024, showing net assets of −£6.87m, with 2 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 305% on the prior period (−£1.70m).
Peer position · net assets
By net assets it sits in the bottom quarter of 603 comparable companies in London (median £440, upper quartile £92k).
02
Ownership and control
No active person with significant control is registered.
- Eliot Robert Charles
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 4 November 20223 yrs ago
- Next accounts due
- 30 September 202623 days overdue
- Confirmation statement due
- 18 November 2026in 26 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not disclosed
2
No changevs Dec 2023| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2024 | −£6.87m | — | — | — | — | — | 2 |
| 31 December 2023 | −£1.70m | — | — | — | — | — | 2 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
06
Filing and accounts signals
- Net assets below zeroNet assets £-6,870,255 at 31 December 2024
- Net assets down 25% or more on the prior period-305.2% vs prior period
- Incorporated two to five years agoIncorporated 4 November 2022
- Accounts past their due dateDue 30 September 2026
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 26 days
- Next accounts due23 days overdue
- Accounts period endNet liabilities £6.87m · micro accounts
- Accounts period endNet liabilities £1.70m · micro accounts
- Incorporated
08
Similar companies in London
- NEUROCYTONIX UK LIMITEDLondon · inc. Oct 2022
- TREAT THERAPEUTICS LTDLondon · inc. Nov 2022
- VECTORBUILDER LIMITEDLondon · inc. Nov 2022
- BEACON THERAPEUTICS LIMITEDLondon · inc. Oct 2022
- SCIENZ LTDLondon · inc. Nov 2022
- SENOREI LIMITEDLondon · inc. Nov 2022
All companies incorporated on 4 November 2022 · in Nov 2022.
09
Reminders for CODIFY THERAPEUTICS LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.